MECOM and neoplasm: Among these, 11 genes—including BIRC3, BTG1, CCR7, HOXC13, IL7R, IRF1, MECOM, NFKB2, NFKBIA, NFKBIE, and WAS —emerged as key players in tumor progression and immune regulation.